Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹456.65
Market cap
₹17,471 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
164.5×Sector 47.4×
Promoter holding
57.49%+0.00% QoQ
FII holding
6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Price Movement Clarification 4Business Update 4Annual General Meeting 4Management Change 3Financial Results 3Earnings Call 3Board Meeting Date 2Results Update 1Results Correction 1Other Announcement 1Merger & Restructuring 1Employee Stock Options 1Credit Rating 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1Acquisition 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

12:15 IST BSE
Board Meeting Date

Cohance Lifesciences Board Meeting Date

Cohance Lifesciences scheduled a board meeting for August 5, 2026. The board will consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗
15:05 IST BSE
Board Meeting Date

Cohance Lifesciences Board Meeting Date

Cohance Lifesciences Ltd has scheduled a Board Meeting on May 12, 2026, to approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until May 14, 2026.

Read the filing ↗